First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay--Lp(a) SRM 2B.
Lipoprotein(a) is an important predictor of cardiovascular disease risk. The lack of internationally accepted standardization has impeded the broad application of this lipoprotein in laboratory medicine. The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), through its Working Group on Lipoprotein(a) and together with research institutions and several diagnostic companies, have succeeded in developing an international reference material that is intended for the transfer of a lipoprotein(a) concentration to manufacturers' master calibrators. IFCC SRM 2B has recently been accepted by the WHO Expert Committee on Biological Standardization as the 'First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay'. The assigned unitage of 0.1071 nanomoles of lipoprotein(a) per vial is traceable to the consensus reference method for lipoprotein(a) and will enable conformity by diagnostic companies to the European Union's Directive on In vitro Diagnostic Medical Devices for the metrological traceability of calibrator materials.
Dati
Francesco
F
IVD-Consulting, Marburg, Germany. f.dati@t-online.de
Tate
Jillian R
JR
Marcovina
Santica M
SM
Steinmetz
Armin
A
D005062:European Union; D006801:Humans; D007118:Immunoassay / Q000592:standards*; D007202:Indicators and Reagents; D007391:International Cooperation; D017270:Lipoprotein(a) / Q000097:blood*; D012015:Reference Standards; D015203:Reproducibility of Results; D014944:World Health Organization
D007202:Indicators and Reagents; D017270:Lipoprotein(a)